CONFERENCE >  AGENDA  
European Primary Immunodeficiencies Consensus Conference

European Primary Immunodeficiencies Consensus Conference
19 – 20 June 2006
Paul-Ehrlich-Institut, Langen, Germany

Partners | Sponsors | Endorsers


Click here to go direct to the EU PID Consensus Statement, Recommendations & Report
 English Français Deutsch Español  Polski

QUICK LINKS

Day 1 : Monday 19 June 10.00 – 16.30

SESSION 1
PIDs – AN EU PUBLIC HEALTH ISSUE

SESSION 2
PIDs – WHAT ARE PRIMARY IMMUNODEFICIENCIES?

SESSION 3
PIDs – CONSEQUENCES OF MISSED OR DELAYED DIAGNOSIS

Day 2 : Tuesday 20 June 09.00 – 16.15

SESSION 4
PUBLIC HEALTH INTERVENTIONS TO ADDRESS PIDs

SESSION 5
DEVELOPMENT OF RECOMMENDATIONS & CONSENSUS FOR PUBLIC HEALTH ACTION TO ADDRESS PIDs IN THE EU


AGENDA

Day 1 : Monday 19 June 10.00 – 16.50

SESSION 1 PIDs – AN EU PUBLIC HEALTH ISSUE
| Moderator: Prof Jose Luis Valverde, European Parliament Representative to EMEA

TIME

TOPIC

SPEAKER

10.00 Arrival  
10.30 Welcome and Introduction Dr Ulrich Kalinke,
Div of Immunology, Paul-Ehrlich-Institut
10.40 Overview of PIDs in the EU, Goals and Objectives of the Meeting Prof Reinhold Schmidt, EFIS
11.00 The Benefits on an EU approach to Rare Diseases Mr Daniel Mann
Health Information Unit, European Commission
11.20 Addressing inequalities of access to healthcare in an expanded EuropeFrançois Houÿez
François Houÿez, Health Policy Officer, EURORDIS
11.40 PID – a Public Health Issue? Prof Edvard Smith, Karolinska Institutet, Stockholm
12.00      

12.20          
Questions and Answers

Lunch
 

>> back to the top

SESSION 2 PIDs – WHAT ARE PRIMARY IMMUNODEFICIENCIES?
| Moderators: Dr Teresa Espanol, IPOPI and Ms Amena Warner, INGID

TIME

TOPIC

SPEAKER

13.20 Overview of Primary Immunodeficiency in adults and children Dr Helen Chapel, John Radcliff Infirmary, Oxford
13.40 Prevalence in the EU Prof Lennart Hammarström, Karolinska Institutet, Stockholm
14.00 Treatment Options: Immunoglobulin Therapy – the Major Therapy Choice in PID. Dr Hilary Longhurst, Barts and The London NHS Trust, London
14.20 Treatment Options: Bone Marrow Transplants/ Gene Therapy Prof Christine Kinnon, Institute of Child Health, London
14.40 Disparity of Diagnosis, Care and Treatment for PIDs between Member States of the EU Dr Anna Sediva, Charles University, Prague
15.00 Refreshment Break  

>> back to the top

SESSION 3 PIDs – CONSEQUENCES OF MISSED OR DELAYED DIAGNOSIS
| Moderators: Ms Bianca Pizzera, IPOPI Chairperson and Prof. Lennart Hammarström, Karolinska University, Stockholm

TIME

TOPIC

SPEAKER

15.20 Consequences of Delayed Diagnosis: Mortality/Morbidity Dr Fulvio Porta, University of Brescia
15.40 Consequences of Delayed Diagnosis: Quality of Life Dr Ann Gardulf, INGID
16.00 Consequences of Delayed Diagnosis: A Patient's Story Ms Jose Drabwell, IPOPI/ PIA
16.20 Consequences of Delayed Diagnosis: Health-care costs Prof Thomas Szucs, Health Economics Institut of Social & Preventive Medicine, University of Zurich
16.40 Day 1 Summary
16.50 Day 1 ends  

>> back to the top

Day 2 : Tuesday 20 June 09.00 – 16.15

SESSION 4 PUBLIC HEALTH INTERVENTIONS TO ADDRESS PIDs
| Moderators: Prof. Edvard Smith, Karolinska Institutet, Stockholm and Mr David Watters, Executive Director, IPOPI

TIME

TOPIC

SPEAKER

09.00 Evaluating Strategies for Early Identification of People with PIDs Prof Reinhold Schmidt, EFIS
09.20 Uses of Genetic Testing for PIDs Dr Jennifer Puck, University of California, San Francisco
09.40 The role of nurses in recognising PIDs Ms Amena Warner,
INGID
10.00 Refreshment Break  
10.20 The importance or patient registries in Rare Diseases Mr Brian O’Mahony, Irish Hemophilia Society
10.40 Educational Outreach Efforts by:
Physicians: J-Projec
t



Patients: US

Patients: Europe


Nurses: UK

Prof László Maródi, University of Debrecen Medical & Health Science Centre, Hungary

Mr Fred Modell,
Jeffrey Modell Foundation

Ms Anneli Larsson, PIO

Dr Peter Vickers, University of Hertfordshire

11.40 What can we learn from the US – what are the positive effects from the US Consensus Conference? Dr Hans Ochs, University of Washington
12.00 Lunch  

>> back to the top

SESSION 5 DEVELOPMENT OF RECOMMENDATIONS & CONSENSUS FOR PUBLIC HEALTH ACTION TO ADDRESS PIDs IN THE EU
| Group Chairs: Dr Helen Chapel, Dr Esther de Vries, Prof Reinhold Schmidt, (each chair Group A, B and C)

TIME

TOPIC

SPEAKER

1330 Breakout Groups

Group A- Awareness and Education (Chair: Dr Helen Chapel)

Group B- Screening and Diagnosis (Chair: Dr Esther de Vries)

Group C- Treatment and Care (Chair: Prof Reinhold Schmidt)

 
15.00 Refreshment Break  
15.15 Group Reports and Recommendations
Group Chairs (15 minutes each)
 
16.00 Meeting closure, wrap up and thanks
Dr Helen Chapel
16.15 End of Conference  

>> back to the top

 IPOPIINGIDESIDEFIS

Conference Diamond Sponsor
NEW

Think like Me